Skip to content
  • Clinical Studies
  • Pharma GMP
  • Pharma Tips
  • Stability Studies
  • Pharma Books
  • Schedule M

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • SOP – Blog Post
  • Toggle search form

SOP for Pharmacokinetic Sampling

Posted on By

Protocol for Blood Sample Collection in BA/BE Studies

Purpose

The purpose of this Standard Operating Procedure (SOP) is to establish guidelines for the collection, handling, and processing of pharmacokinetic (PK) blood samples in Bioavailability (BA) and Bioequivalence (BE) studies conducted in the pharmaceutical industry.

Scope

This SOP applies to all personnel involved in the planning, collection, handling, and analysis of PK blood samples, including Clinical Research Associates (CRAs), Study Nurses, Laboratory Personnel, and Data Managers.

Responsibilities

  • The Study Coordinator is responsible for coordinating PK sample collection activities and ensuring compliance with the study protocol and regulatory requirements.
  • The Study Nurse or Phlebotomist is responsible for collecting blood samples from study participants according to the specified sampling schedule and procedures.
  • The Laboratory Personnel are responsible for processing and analyzing PK blood samples, including sample storage, centrifugation, and analysis techniques.
See also  SOP for Handling Unblinding Procedures

Procedure

  1. Develop a PK sampling plan detailing the timing, frequency, and volume of blood samples to be collected based on the study protocol and pharmacokinetic objectives.
  2. Train study personnel involved in sample collection on proper phlebotomy techniques, sample handling, and documentation procedures.
  3. Coordinate with study participants to schedule PK sampling visits and provide clear instructions on fasting requirements, medication restrictions, and other relevant instructions.
  4. Collect blood samples using aseptic techniques and appropriate collection devices, ensuring
correct labeling and documentation of sample collection times.
  • Process blood samples promptly according to the study protocol, including centrifugation, aliquoting, and storage at specified temperatures.
  • Transfer processed samples to the laboratory for analysis, maintaining appropriate chain of custody and documentation throughout the process.
  • Analyze PK blood samples using validated analytical methods and instruments, ensuring accuracy, precision, and reliability of results.
  • Document all PK sample collection, handling, and analysis activities in the study records, including any deviations or incidents encountered.
  • Abbreviations

    • SOP – Standard Operating Procedure
    • BA – Bioavailability
    • BE – Bioequivalence
    • PK – Pharmacokinetic
    • CRA – Clinical Research Associate

    Documents

    • PK Sampling Plan
    • Phlebotomy Training Records
    • Sample Collection Log
    • Sample Analysis Reports

    Reference

    International Conference on Harmonisation (ICH) E6 Good Clinical Practice guidelines and relevant regulatory requirements for bioanalytical method validation and sample handling.

    SOP Version

    Version 1.0

    See also  SOP for Interim Analysis and Data Monitoring
    Bioequivalence Bioavailability Study Tags:AUC (area under the curve), BE assessment, Bioavailability study, Bioequivalence study, clinical trials, Cmax (maximum concentration), Comparative pharmacokinetics, Drug absorption, Drug absorption rate, Drug bioanalysis, Drug development, Drug dissolution, Drug formulation, Drug metabolism, In vitro bioequivalence, In vivo bioavailability, Pharmacokinetic parameters, Pharmacokinetics, SOP for Bioavailability study, SOP for Bioequivalence study, Therapeutic equivalence, Tmax (time to maximum concentration)

    Post navigation

    Previous Post: SOP for Clinical Monitoring and Site Management
    Next Post: SOP for Blood Sample Collection

    Standard Operating Procedures V 1.0

    • Aerosols
    • Analytical Method Development
    • Bioequivalence Bioavailability Study
    • Capsule Formulation
    • Clinical Studies
    • Creams
    • Data Integrity
    • Dental Dosage Forms
    • Drug Discovery
    • Environment, Health and Safety
    • Formulation Development
    • Gels
    • Good Distribution Practice
    • Good Warehousing Practices
    • In-Process Control
    • Injectables
    • Liquid Orals
    • Liposome and Emulsion Formulations
    • Lotions
    • Lyophilized Products
    • Maintenance Dept.
    • Medical Devices
    • Metered-Dose Inhaler
    • Microbiology Testing
    • Nanoparticle Formulation
    • Nasal Spray Formulations
    • Nebulizers
    • Ocular (Eye) Dosage Forms
    • Ointments
    • Otic (Ear) Dosage Forms
    • Pharmacovigilance
    • Powder & Granules
    • Purchase Departments
    • Quality Assurance
    • Quality Control
    • Raw Material Stores
    • Regulatory Affairs
    • Tablet Manufacturing
    • Rectal Dosage Forms
    • Transdermal Patches
    • Vaginal Dosage Forms
    • Validations and Qualifications

    Read SOPs in your Language:

     - 
    Bengali
     - 
    bn
    English
     - 
    en
    Gujarati
     - 
    gu
    Hindi
     - 
    hi
    Malayalam
     - 
    ml
    Marathi
     - 
    mr
    Punjabi
     - 
    pa
    Tamil
     - 
    ta
    Telugu
     - 
    te

    NEW! Revised SOPs – V 2.0

    • Aerosols V 2.0
    • Analytical Method Development V 2.0
    • API Manufacturing V 2.0
    • BA-BE Studies V 2.0
    • Biosimilars V 2.0
    • Capsules V 2.0
    • Creams V 2.0
    • Elixers V 2.0
    • Ointments V 2.0
    • Raw Material Warehouse V 2.0
    • Tablet Manufacturing V2.0

    New Publication: A must for All.

    Copyright © 2025 SOP Guide for Pharma.

    Powered by PressBook WordPress theme

    Go to mobile version